Company intelligence / Profile preview

NO2U

Austin, Texas, United States

Ownership: Private
Development stage: Other

Overview

NO2U is a biotechnology and health sciences company specializing in the development of nitric oxide-based delivery systems. Founded by Dr. Nathan Bryan, a pioneer in molecular medicine, the company focuses on addressing the systemic decline of nitric oxide that occurs with aging. NO2U's proprietary technology includes an orally disintegrating lozenge that generates bioactive nitric oxide gas to support cardiovascular health and circulation. Beyond its commercial supplement line, the company is involved in research exploring the therapeutic potential of nitric oxide for various metabolic and inflammatory conditions. Their mission is to provide innovative solutions that restore essential signaling molecules to improve human longevity and vitality.

Therapeutic areas: NeurologyCardiovascularMen's HealthDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on NO2U.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NO2U.

Explore the full profile